GERN · NASDAQ
Geron (GERN) Stock Price & Fundamentals
Geron (GERN) closed at $1,112.72 on Oct 9, 2026, down 0.98% from the previous close of $1,123.75.
Share price, past year
1Y +48.32%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,112.72 |
| Sep 30, 2026 | $1,133.09 |
| Aug 31, 2026 | $1,129.07 |
| Jul 31, 2026 | $1,131.26 |
| Jun 30, 2026 | $1,021.91 |
| May 29, 2026 | $1,021.87 |
| Apr 30, 2026 | $926.20 |
| Mar 31, 2026 | $888.61 |
| Feb 27, 2026 | $873.71 |
| Jan 30, 2026 | $821.60 |
| Dec 31, 2025 | $786.94 |
| Nov 28, 2025 | $766.80 |
| Oct 31, 2025 | $744.81 |
Key statistics
- Market cap
- $711.98B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.11
- Revenue (TTM)
- —
- Net income (TTM)
- −$67.61M
- Shares outstanding
- 639.9M
- Dividend yield
- —
- 52-week range
- $728.26 – $1,190.63
Geron's market cap is $711.98B, based on a share price of $1,112.72 and 639.9M shares outstanding as of Dec 31, 2025.
Financials
Geron reported revenue of $237.00K for fiscal 2023, down 60.23% from fiscal 2022.
Geron reported a net loss of $83.50M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2023ended Dec 31, 2023 | $237.00K | −60.2% | −$184.13M | −77,690.7% | −$0.32 | −$168.57M |
| FY2022ended Dec 31, 2022 | $596.00K | −57.2% | −$141.90M | −23,808.9% | −$0.37 | −$127.81M |
| FY2021ended Dec 31, 2021 | $1.39M | +450.6% | −$116.11M | −8,335.4% | −$0.35 | −$95.76M |
| FY2020ended Dec 31, 2020 | $253.00K | −45.0% | −$75.62M | −29,888.1% | −$0.28 | −$67.05M |
| FY2019ended Dec 31, 2019 | $460.00K | −56.9% | −$68.55M | −14,901.7% | −$0.36 | −$44.24M |
| FY2018ended Dec 31, 2018 | $1.07M | +0.1% | −$27.02M | −2,534.4% | −$0.15 | −$21.03M |
| FY2017ended Dec 31, 2017 | $1.07M | −82.7% | −$27.92M | −2,621.2% | −$0.18 | — |
| FY2016ended Dec 31, 2016 | $6.16M | −83.1% | −$29.54M | −479.3% | −$0.19 | −$18.43M |
| FY2015ended Dec 31, 2015 | $36.37M | +3,054.5% | — | — | — | −$24.29M |
| FY2014ended Dec 31, 2014 | $1.15M | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $57.48M | −$16.68M | −$0.02 |
| Q1 FY2026ended Mar 31, 2026 | $51.84M | −$3.64M | −$0.01 |
| Q3 FY2025ended Sep 30, 2025 | $47.23M | −$18.43M | −$0.03 |
| Q2 FY2025ended Jun 30, 2025 | $49.04M | −$16.38M | −$0.02 |
| Q1 FY2025ended Mar 31, 2025 | $39.60M | −$19.84M | −$0.03 |
| Q3 FY2024ended Sep 30, 2024 | $28.27M | −$26.45M | −$0.04 |
| Q2 FY2024ended Jun 30, 2024 | $882.00K | — | — |
| Q1 FY2024ended Mar 31, 2024 | $304.00K | — | — |
Company profile
- Name
- Geron Corporation
- Ticker
- GERN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 919 East Hillsdale Boulevard, Suite 250, Foster City, CA 94404
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000886744
Recent SEC filings
- Aug 6, 2026
- Aug 5, 2026
- May 27, 2026
- May 6, 2026
- Mar 26, 2026
- Mar 2, 2026
- Feb 25, 2026
- Jan 12, 2026
Frequently asked questions
What is Geron's stock price?
Geron (GERN) closed at $1,112.72 on Oct 9, 2026, down 0.98% from the previous close of $1,123.75.
What is Geron's market cap?
Geron's market cap is $711.98B, based on a share price of $1,112.72 and 639.9M shares outstanding as of Dec 31, 2025.
How much revenue does Geron make?
Geron reported revenue of $237.00K for fiscal 2023, down 60.23% from fiscal 2022.
Does Geron pay a dividend?
Geron's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Geron Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures